VaxGen and Raven to Merge

Two South San Francisco biotech firms, the struggling VaxGen and Raven biotechnologies, inc., have agreed to merge in an all-shares transaction.

Shareholders in VaxGen, which has suffered a series of well-publicised setbacks including the failure of an AIDS vaccine in 2003, delisting from Nasdaq in 2004 and the loss of a U.S. government anthrax vaccine contract in 2006, will retain a majority ofshares in the new company, the company said in a statement released Monday. Vaxgen will also assume the privately-held Raven’s debt and equipment lease obligations of approximately $1.8 million, and move its headquarters to Raven’s offices.

Vaxgen is required as part of the merger to relist with a national stock exchange, a step that company officials said is underway.

The merged company’s board will include four Vaxgen board members and three Raven board members. Raven CEO George F. Schreiner will serve as CEO and director of the new company, with Vaxgen President and CEO James P. Panek to serve as president and chief operating officer.

The combined company will have one compound for major cancer indications in clinical development, four oncology product candidates in preclinical development, and a library of antibodies to novel cancer antigens, the companies said in a statement.

If you find our journalism valuable and relevant, please consider joining our Examiner membership program.
Find out more at www.sfexaminer.com/join/

Just Posted

From auto burglaries to homicides, crime fell in San Francisco in 2019

In the face of national scrutiny over street conditions in San Francisco,… Continue reading

Chinese coronavirus outbreak has reached the U.S.

The patient, who recently traveled to the outbreak’s epicenter, was hospitalized last week with pneumonia-like symptoms.

BART to vote this week on Market Street station canopy project

Shelters for station entrances expected to reduce escalator breakdowns

Thin margin in SF police union election triggers runoff

Police in San Francisco are deeply divided over who should be the… Continue reading

Deal reached to purchase home at center of Moms 4 Housing protest

Oakland Community Land Trust to buy property under agreement with investment firm

Most Read